Home pharmabiotech
 

Keywords :   


Tag: pharmabiotech

What Pharma/Biotech Investors Need To Know About Adaptive Trials

2016-01-16 19:10:13| Biotech - Topix.net

The FDA allows for adaptive drug trials during which key protocols may be altered during the course of the trial depending on interim results. Investors concerned with pharmaceutical or biotech drug development, from early to late stages, need to be aware of the benefits and risks of adaptive trials because their use and interpretation can impact corporate valuations.

Tags: investors trials adaptive pharmabiotech

 

Alpha Controls offers world-class instruments for pharma/biotech, and food and beverage industries

2016-01-09 00:48:03| Canadian Plastics Headlines

As a leading supplier of measuring, sensing and controlling instruments, Alpha Controls offers instrumentation from top manufacturers like Mettler Toledo. The post Alpha Controls offers world-class instruments for pharma/biotech, and food and beverage industries appeared first on Canadian Plastics.

Tags: offers food instruments industries

 
 

Kyle Bass Loses Round 1 of IPR Attack Against Pharma/Biotech Patents

2015-08-29 06:06:18| Biotech - Topix.net

On August 24, 2015, the Patent Trial and Appeal Board declined institution of two petitions filed by Coalition For Affordable Drugs for Inter Partes Reviews of Acorda's patents covering Ampyra, a billion-dollar drug for treating multiple sclerosis. The Petitioner, Coalition For Affordable Drugs, is a wholly owned subsidiary of a hedge fund managed by Kyle Bass, which appears to have little to do with the life science and drug industry other than filing IPR petitions against patents owned by pharmaceutical and biotechnology companies.

Tags: round attack bass patents

 

Research and Markets: Regulatory Trends in the US Pharma/Biotech Industry 2015

2015-04-10 14:07:56| Biotech - Topix.net

This market insight provides an analysis of the regulatory trends occurring in the US pharma/biotech industry for 2014. Included in this deliverable is an analysis of the new molecular entities approved by the US Food and Drug Administration in 2014 and predictions for 2015.

Tags: research industry markets trends

 

Sites : [1]